Human breast cancer cells selected for resistance to trastuzumab in vivo overexpress epidermal growth factor receptor and ErbB ligands and remain dependent on the ErbB receptor network
published in: Clinical Cancer Research
date of publication: 2007-08-01
language: English
main subject: breast cancer, trastuzumab
Cites articles
There is nothing here
Article - wd:Q40093663